2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | 10.454 | 64.729 | 111.855 | 54.483 | 132.216 | 171.146 | 141.231 | 82.907 | 102.824 |
Total Income - EUR | - | 12.674 | 99.313 | 138.363 | 82.168 | 118.374 | 192.253 | 180.397 | 166.133 | 187.791 |
Total Expenses - EUR | - | 7.466 | 81.855 | 122.740 | 109.999 | 105.992 | 102.187 | 128.192 | 152.308 | 181.703 |
Gross Profit/Loss - EUR | - | 5.208 | 17.458 | 15.622 | -27.831 | 12.382 | 90.065 | 52.205 | 13.825 | 6.087 |
Net Profit/Loss - EUR | - | 4.376 | 14.665 | 14.756 | -28.316 | 11.950 | 89.640 | 51.696 | 13.483 | 5.604 |
Employees | - | 0 | 1 | 2 | 3 | 2 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Biodantera Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | - | 81 | 0 | 93.144 | 248.052 | 267.495 | 659.345 | 1.518.015 | 2.301.832 | 2.416.259 |
Current Assets | - | 13.209 | 96.117 | 352.058 | 1.376.243 | 2.072.654 | 1.574.878 | 1.368.632 | 815.796 | 777.411 |
Inventories | - | 2.211 | 30.991 | 48.095 | 65.824 | 22.743 | 8.702 | 13.270 | 36.924 | 38.514 |
Receivables | - | 10.454 | 64.864 | 41.971 | 1.055.454 | 1.805.188 | 1.496.951 | 1.294.676 | 701.592 | 675.429 |
Cash | - | 544 | 263 | 261.992 | 254.966 | 244.722 | 69.225 | 60.686 | 77.280 | 63.469 |
Shareholders Funds | - | 4.421 | 19.041 | 33.475 | 4.545 | 16.407 | 105.736 | 155.087 | 169.051 | 174.142 |
Social Capital | - | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | - | 8.869 | 77.076 | 393.911 | 601.407 | 599.164 | 463.011 | 1.134.042 | 1.380.390 | 1.485.652 |
Income in Advance | - | 0 | 0 | 17.817 | 1.018.344 | 1.724.578 | 1.665.476 | 1.597.518 | 1.571.354 | 1.535.562 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "111 - 111" | |||||||||
CAEN Financial Year |
111
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Biodantera Srl